AMCP expresses our strong support for H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act, bipartisan legislation to increase competition and patient access to safe and affordable generic and biosimilar medicines. AMCP is pleased with the reintroduction of the legislation into the 116th Congress on February 5, 2019.